Boehringer Ingelheim Venture Fund
Venture capitalIngelheim am Rhein · Seed–Series B · 9 people tracked
Team · 9 people
from the firm's websiteFrequently asked questions
- What stage does Boehringer Ingelheim Venture Fund invest at?
- Boehringer Ingelheim Venture Fund invests at the Seed, Series A, Series B stages.
- What is Boehringer Ingelheim Venture Fund's typical check size?
- Boehringer Ingelheim Venture Fund typically writes checks of $16.2M.
- What sectors does Boehringer Ingelheim Venture Fund focus on?
- Boehringer Ingelheim Venture Fund focuses on Biotech, Medical Devices.
- Where is Boehringer Ingelheim Venture Fund located?
- Boehringer Ingelheim Venture Fund is headquartered in Ingelheim am Rhein, DE.
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.